Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. HeartWare closes enrollment in destination therapy trial for heart pump
HeartWare announced that it completed enrollment in a 450-patient clinical trial considering its HVAD pump as a destination therapy for patients with advanced heart failure.
2. St. Jude lands FDA wins for CRM devices reducing unneeded shocks
St. Jude Medical touts a pair of FDA wins for its Ellipse and Assura implantable cardiac defibrillators, both of which feature technology designed to reduce unnecessary shocks to the heart.
1. DePuy hip battle wages on in the pages of the British Medical Journal
A battle rages on the pages of the British Medical Journal, with researchers warning that patients may have been exposed to toxic compounds and DePuy representatives calling the reports "unnecessarily alarmist."
